United Kingdom
2
2018-09-13
2
2019-07-02
These are the the leading inventors for applications assigned to IOmet Pharma Ltd.:
IOmet Pharma Ltd. based in , GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Substituted 1H-indole-2-carboxamide compounds as indoleamine-2,3-dioxygenase inhibitors
#2 | 2018-02-08 ✅ Patent 10,287,252 granted on 2019-05-14Inhibitors of tryptophan-2,3-dioxygenase or indoleamine-2,3-dioxygenase
554901 ⎘